AFT gains Australian registration for intravenous Maxigesic

AFT gains Australian registration for intravenous Maxigesic
Jenny Ruth
By Jenny Ruth July 24 (BusinessDesk) - AFT Pharmaceuticals says it has successfully registered the intravenous form of its Maxigesic medication with Australia’s Therapeutic Goods Administration. The intravenous product contains 1,000 milligrams of paracetamol and 300mg of ibuprofen in a 100 millilitre solution. The company says it expects to sell the product in Australia during the year ending March 2020 and the registration “clears the way for regulatory filings in a number of other territories including but not limited to Mexico, Sou...

More Services

Auckland accountancy snapped up by Hong Kong firm Acclime
Services

Auckland accountancy snapped up by Hong Kong firm Acclime

It is the second Auckland firm Acclime has acquired in as many years.

John Anthony 11 Apr 2025
Engineering firms lose 1200 people in a year
Services

Engineering firms lose 1200 people in a year

But despite the job numbers, most firms were optimistic about the sector’s prospects.

Staff reporters 09 Apr 2025
Former school lunch provider in liquidation
Law & Regulation

Former school lunch provider in liquidation

Secret Chef stopped trading in December last year.

Michael Neilson 18 Mar 2025
Libelle approached liquidators late last week
Services Exclusive

Libelle approached liquidators late last week

Liquidators were called on the same day a student was burned by a meal.

Cécile Meier 11 Mar 2025